SCHEMBL943647

SCHEMBL943647

CC(C(=O)NC1CCC1)N1CCN2CCC[C@@H]2C1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
SIGMAR1 Q99720 8/20 0.53
CHRM5 P08912 2/20 0.48
CHRM1 P11229 2/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM3 P20309 1/20 0.48
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CASP6 P55212 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL943649 1.00 KDM4E (0.56) KDM4ESIGMAR1CHRM5CHRM1CHRM2
SCHEMBL29957083 0.72 KDM4E (0.56) KDM4ESIGMAR1ALDH1A1CASP6GAA
SCHEMBL977989 0.72 KDM4E (0.58) KDM4ESIGMAR1CHRM5CHRM3ALDH1A1
SCHEMBL12250826 0.71 MEN1 (0.40) KDM4ESIGMAR1CHRM5CHRM1CHRM2
SCHEMBL1083799 0.71 MEN1 (0.40) KDM4ESIGMAR1CHRM5CHRM1CHRM2
SCHEMBL12250827 0.71 MEN1 (0.40) KDM4ESIGMAR1CHRM5CHRM1CHRM2
SCHEMBL29956109 0.70 KDM4E (0.50) KDM4ESIGMAR1ALDH1A1CASP6GAA
SCHEMBL979295 0.69 SIGMAR1 (1.00) KDM4ESIGMAR1CHRM5CHRM1CHRM2
SCHEMBL19046434 0.69 KDM4E (0.77) KDM4ESIGMAR1ALDH1A1CASP6GAA
SCHEMBL27737514 0.69 SIGMAR1 (0.45) SIGMAR1CHRM1CHRM2POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed